Search results
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 7 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 7 days agoSeagen drugs contributed $742 million to the top line in the first quarter. Revenues from Pfizer’s...
Novavax's stock surges almost 300% in the past month
AOL· 17 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA) today finally set ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 6 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoPfizer Is Aiming To Set The Treatment Standard For Lung Cancer With encouraging results, Pfizer is...
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman ...
Moderna wins second product approval with RSV vaccine
Morningstar· 7 days agoModerna Inc.'s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA < ...
Moderna wins second product approval with RSV vaccine
Market Watch· 7 days agoThe Food and Drug Administration approved the mRNA shot, mResvia, for adults 60 and older,...
US approves Moderna’s RSV vaccine for older adults | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 7 days agovaccine for older adults — marking the first time any mRNA shot has been authorized against a...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 7 days agoThere are already two approved vaccines for those aged 60 and over, by GSK and Pfizer, both of which have been on the market since last year. "The FDA...